Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | PDK1 | Q15118 | 3/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1005637 | 0.82 | SMN1; SMN2 (0.51) | SMN1; SMN2ALDH1A1TDP1TSHRPDK1 | |
| SCHEMBL27816552 | 0.72 | SMN1; SMN2 (0.54) | SMN1; SMN2ALDH1A1TDP1TSHRPDK1 | |
| SCHEMBL28377554 | 0.72 | SMN1; SMN2 (0.44) | SMN1; SMN2ALDH1A1TDP1TSHRPDK1 | |
| SCHEMBL5598454 | 0.72 | SMN1; SMN2 (0.49) | SMN1; SMN2ALDH1A1TDP1TSHR | |
| SCHEMBL18420005 | 0.72 | EPHX1 (0.31) | — | |
| SCHEMBL8096575 | 0.72 | SMN1; SMN2 (0.44) | SMN1; SMN2ALDH1A1TDP1TSHRPDK1 | |
| SCHEMBL27985998 | 0.72 | SMN1; SMN2 (0.33) | SMN1; SMN2ALDH1A1TDP1 | |
| SCHEMBL12079083 | 0.71 | LMNA (0.37) | SMN1; SMN2ALDH1A1TDP1TSHRPDK1 | |
| SCHEMBL28292332 | 0.71 | SMN1; SMN2 (0.51) | SMN1; SMN2ALDH1A1TDP1TSHRPDK1 | |
| SCHEMBL13301287 | 0.70 | SMN1; SMN2 (0.48) | SMN1; SMN2ALDH1A1TDP1TSHRPDK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8986923-B2 | Aqueous base-developable negative-tone films based on functionalized norbornene polymers | PROMERUS, LLC (US) | 2015-03-24 | — | — | US | claimed |
| US-20140038112-A1 | AQUEOUS BASE-DEVELOPABLE NEGATIVE-TONE FILMS BASED ON FUNCTIONALIZED NORBORNENE POLYMERS | PROMERUS, LLC (US) | 2014-02-06 | — | — | US | claimed |
| US-8580477-B2 | Aqueous base-developable negative-tone films based on functionalized norbornene polymers | PROMERUS LLC (US) | 2013-11-12 | — | — | US | claimed |
| US-20110070543-A1 | Aqueous Base-Developable Negative-Tone Films Based On Functionalized Norbornene Polymers | PROMERUS LLC (US) | 2011-03-24 | — | — | US | claimed |
| EP-3883745-A1 | PRECISION SYSTEM FOR ADDITIVE FABRICATION | Inkbit, LLC (US) | 2021-09-29 | — | — | EP | disclosed |
| WO-2020123479-A1 | PRECISION SYSTEM FOR ADDITIVE FABRICATION | Inkbit, LLC (US) | 2020-06-18 | — | — | WO | disclosed |
| US-8986923-B2 | Aqueous base-developable negative-tone films based on functionalized norbornene polymers | PROMERUS, LLC (US) | 2015-03-24 | — | — | US | disclosed |
| US-20140038112-A1 | AQUEOUS BASE-DEVELOPABLE NEGATIVE-TONE FILMS BASED ON FUNCTIONALIZED NORBORNENE POLYMERS | PROMERUS, LLC (US) | 2014-02-06 | — | — | US | disclosed |
| US-8580477-B2 | Aqueous base-developable negative-tone films based on functionalized norbornene polymers | PROMERUS LLC (US) | 2013-11-12 | — | — | US | disclosed |
| US-20110070543-A1 | Aqueous Base-Developable Negative-Tone Films Based On Functionalized Norbornene Polymers | PROMERUS LLC (US) | 2011-03-24 | — | — | US | disclosed |
| US-6838515-B2 | Process for the preparation of esters of (meth)acrylic acid | DSM IP ASSETS B.V. (NL) | 2005-01-04 | — | — | US | disclosed |
| US-6714712-B2 | URETHANE-FREE POLYESTER ACRYLATE OLIGOMERS HAVE ALSO BEEN USED IN RADIATION-CURABLE COATING COMPOSITIONS FOR OPTICAL GLASS FIBERS | DSM N.V. (NL) | 2004-03-30 | — | — | US | disclosed |
| EP-1385893-A2 | RADIATION CURABLE COATING COMPOSITION | DSM IP Assets B.V. (NL) | 2004-02-04 | — | — | EP | disclosed |
| EP-1353893-A1 | PROCESS FOR THE PREPARATION OF ESTERS OF (METH)ACRYLIC ACID | Dsm N.V. (NL) | 2003-10-22 | — | — | EP | disclosed |
| US-20020168164-A1 | Radiation curable coating composition | DSM IP ASSETS B.V. (NL) | 2002-11-14 | — | — | US | disclosed |
| US-20020156317-A1 | Process for the preparation of esters of (meth)acrylic acid | DSM IP ASSETS B.V. (NL) | 2002-10-24 | — | — | US | disclosed |
| WO-2002055574-A2 | RADIATION CURABLE COATING COMPOSITION | DSM NV (NL) | 2002-07-18 | — | — | WO | disclosed |
| WO-2002055473-A1 | PROCESS FOR THE PREPARATION OF ESTERS OF (METH)ACRYLIC ACID | DSM IP ASSETS B.V. (NL) | 2002-07-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020156317-A1 | Process for the preparation of esters of (meth)acrylic acid | ADH1A, PAM, OXGR1 | SMN1; SMN2 3788/4885ALDH1A1 181/4885TDP1 3600/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.